Medipal Holdings (7459) · FactRestated
Addition of かちどき薬品株式会社 to the Scope of Equity-Method Accounting
First written in FY2022-Q1. 2 of 3 entries say "Restated". Latest entry: FY2022.
3entries
2years
0from disclosures
How it moved
Same theme, other companies
Addition of an Associate to the Equity Method Due to Increased MaterialityA theme 52 companies write about · 1 as a headwind · 7 as a tailwind
The whole theme swung hardest in 2026: 3 of 13 companies on the "Worse" side.
21 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 52 companies compared. The sentences above are computed from all 52.Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「From the current consolidated fiscal year, かちどき薬品株式会社 has been included in the scope of equity-method accounting because its materiality has increased.」
The inclusion of かちどき薬品 in the scope of equity-method accounting remains in place because its materiality has increased. - FY2022-Q2RestatedAnnual report
「From the first quarter of the current consolidated accounting period, かちどき薬品株式会社 has been included in the scope of equity-method accounting because its materiality has increased.」
The inclusion of かちどき薬品 in the scope of equity-method accounting remains in place. - FY2022-Q1First statedAnnual report
「From the first quarter of the current consolidated accounting period, かちどき薬品株式会社 has been included in the scope of equity-method accounting because its materiality has increased.」
かちどき薬品株式会社 was added to the scope of equity-method accounting from the first quarter of the current consolidated accounting period because its materiality had increased.